Othman, J., Potter, N., Freeman, S. D., McCarthy, N., Jovanovic, J., Runglall, M., Canham, J., Thomas, I., Johnson, S., Gilkes, A., Cavenagh, J., Kottaridis, P., Taussig, D., Arnold, C., Hemmaway, C., Culligan, D., Overgaard, U. M., Dennis, M., Burnett, A. K., Russell, N. H., Dillon, R. (2025). Induction chemotherapy and molecular MRD influence outcomes in
                    <i>KMT2A</i>
                    -rearranged AML. Blood. https://doi.org/10.1182/blood.2025029556